Keith Woods, Advisor
Keith Woods has over 30 years of experience in the biopharmaceutical industry. He previously served as Chief Operating Officer at argenx, where he remains as an advisor to the Board of Directors. Prior to argenx, Mr. Woods served as Senior Vice President of North American Operations for Alexion Pharmaceuticals where he managed a team of several hundred people in the U.S. and Canada and was responsible for more than $1 billion in annual sales. Within Alexion, Mr. Woods had previously served as Vice President and Managing Director of Alexion UK, overseeing all aspects of Alexion’s UK business, and Vice President of U.S. Operations and Executive Director of Sales, leading the launch of Soliris in atypical hemolytic uremic syndrome. Prior to Alexion, Mr. Woods held various positions of increasing responsibility within Roche, Amgen, and Eisai over a span of 20 years. He serves as a member of the Board of Directors of Rocket Pharmaceuticals, TScan Therapeutics, and X4 Pharmaceuticals. Mr. Woods received his B.S. in Marketing from Florida State University.